Madrigal Pharmaceuticals, Inc. (MDGL)
586.21
+6.32
(+1.09%)
USD |
NASDAQ |
Dec 04, 16:00
586.25
+0.04
(+0.01%)
After-Hours: 20:00
Madrigal Pharmaceuticals Shareholders Equity (Quarterly): 625.73M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Amicus Therapeutics, Inc. | 230.42M |
| Insmed, Inc. | 945.57M |
| Krystal Biotech, Inc. | 1.138B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.362B |
| Total Liabilities (Quarterly) | 736.72M |
| Debt to Equity Ratio | 0.5536 |
| Current Ratio | 3.441 |
| Net Debt Paydown Yield | -0.44% |